Background
==========

Chronic diseases constitute a major global health burden. In the United Arab Emirates one in four people has diabetes, and disorders such as hypertension, asthma, and dyslipidemia are highly prevalent even in early adulthood \[[@B1],[@B2]\]. The quality of care that these patients receive has a tremendous impact on their prognosis and quality of life.

It is well recognized that tight control of hypertension, glycemia and cholesterol are all effective methods of reducing morbidity and mortality \[[@B3]-[@B5]\]. In addition there is strong evidence of a positive synergy between these interventions \[[@B6]\], so comprehensive care provided by a single care provider should be the most efficient.

In recent years the role of Primary Health Care has been emphasized as the most cost-effective form of care utilizing standardized pharmacologic regimens that involve a limited number of widely used and relatively nontoxic agents \[[@B7]\]. Standards of care for various chronic diseases have been defined in the context of simple evidence based clinical practice guidelines. Nevertheless, many reports have shown that adherence to standards, despite their simplicity, has often remained low. Training of health care professionals, while essential, is only one part of the solution and would have only a limited impact unless the health system is designed to facilitate the delivery of quality care.

To improve the quality of care, its structure, process, and outcome must all be targeted \[[@B8]\]. It is the design of the care system that determines chronic care quality \[[@B7]\], thus the most successful initiatives are those focusing on the health care system as a whole, such as the Chronic Disease Model which has been developed and implemented in many parts of the world \[[@B9]-[@B15]\].

In Al Ain, in 2003, a primary health care project to improve the quality of care provided to patients with diabetes and hypertension was initiated. Its three main objectives were to optimize resource utilization, to improve the management and outcome of care for patients with diabetes and hypertension based on evidence based guidelines, and to improve Health Care Professionals\' knowledge and adherence to up-to-date evidence based clinical practice guidelines and thereby improves patients\' quality of life and satisfaction.

Settings and Methods
====================

Settings
--------

Al Ain is the fourth largest city in the United Arab Emirates with a population of around 400,000 people, of which a quarter are United Arab Emirates (UAE) nationals and the rest expatriates. Since the early 1980s Al Ain primary health care department has operated eleven centrally managed health care centers within the city as well as eight smaller rural centers that serve the periphery of Al Ain. These centers provide highly accessible services to UAE nationals without the need for appointments. As they are free to Nationals and also are connected to the two main hospitals in the city by a good referral system, they are generally preferred to private clinics, especially for chronic conditions. Services at these centres are provided from 8 am to 11 pm during regular week days by staff working in two shifts; with some centers also providing weekend services. These health centers cater for routine ambulatory care and emergency services as well as vaccination, antenatal care and the primary care of chronic disease.

With a single body providing all primary care, Al Ain\'s primary health care indicators for many areas, such as vaccination are good (coverage 97%). Nevertheless, rapid population growth puts pressure on service provision and concerns were raised with regards to the cost-effectiveness of the long opening hours and poor control of patient flow in the current walk-in system. Health care staff complain of insufficient time per patient during peak hours, especially for those needing more focused care such as diabetics, asthmatics, hypertensives or antenatal patients. To improve this situation a special program was initiated in all 10 urban health care centers - the subject of this study.

Most Health Care Professionals working in these centers are non UAE nationals who have been working in their center for more than 5 years. Few have postgraduate degrees in family medicine or any other medical specialty.

Methods
=======

Table ([1](#T1){ref-type="table"}) shows an overview of the project which consisted of multiple interventions with different strategies to be implemented in four stages.

###### 

The major components of the project, including organizational interventions and interventions targeting both patients and health care professionals

  Stage                                         Intervention                         Details/Strategies                                                                                                                                            Aim of intervention
  --------------------------------------------- ------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **I. Assessment**                             **Flow Audit**                       Snapshot of 1-3 days in all centers over all hours covered and of all services                                                                                To study patient service mismatch
                                                                                                                                                                                                                                                   
                                                **Prevalence Study**                 Prevalence of conventional CVD risk factors assessed                                                                                                          Quantify problem in community served
                                                                                                                                                                                                                                                   
                                                **Care of Chronic Disease Audit**    Chart audit of care of DM & HTN                                                                                                                               Determine baseline measures of process and outcome of care for the population studied
                                                                                                                                                                                                                                                   
  **II. Evolving Intervention**                 **Audit Feedback**                   Presentation of the audit results with document of audit summary distributed in a CME presenting recommended care as well.                                    Stat current practice for the HCP for awareness and reflection and to facilitate uptake of change
                                                                                                                                                                                                                                                   
                                                **Educational Meetings**             Ongoing educational activities through CME/CNE/workshops for doctors and nurses that focused on the different aspects of the project                          Venue to disseminate audit feedback and guidelines
                                                                                                                                                                                                                                                   
                                                **Piloting**                         Tailored intervention piloted in one of the centers and regularly audited including repeat of patient flow study                                              Trial of the intervention on small scale that can be monitored and adjusted easily and further to use it as a successful example to facilitate change of other centers
                                                                                                                                                                                                                                                   
                                                **Administration**                   Leadership commitment Multidisciplinary participation                                                                                                         To ensure commitment, support and ongoing follow up.
                                                                                                                                                                                                                                                   
                                                                                     Overall coordinator assigned                                                                                                                                  
                                                                                                                                                                                                                                                   
                                                                                     Facilitators for the different tasks                                                                                                                          
                                                                                                                                                                                                                                                   
  **III. Intervention**                         **Decision Making Aids and Tools**   Follow-up sheets in the chart (colour coded) with reminders of recommended standard of care                                                                   To ensure adherence by reminders during consultation and decrease variability
                                                                                                                                                                                                                                                   
                                                                                     Clinical Practice Guidelines distributed                                                                                                                      To ensure implementing evidence based practice and decrease variability
                                                                                                                                                                                                                                                   
  **\"The structured Care\"**                                                        Daily appointment based clinics for DM and HTN patients                                                                                                       To provide protected time for the doctor and patients in clinics preset according to recommended care.
                                                                                                                                                                                                                                                   
                                                **System Change**                    Open access to laboratory and drug formulary                                                                                                                  To support and facilitate adherence
                                                                                                                                                                                                                                                   
                                                                                     Calling reminder system of appointments.                                                                                                                      To increase show rate in clinics
                                                                                                                                                                                                                                                   
                                                                                     Accessibility daily to lab at the point of care in all centers                                                                                                To support and facilitate adherence
                                                                                                                                                                                                                                                   
                                                **Information**                      Implementing diabetic and hypertensive Evidence-Based Guidelines through the work of the local Clinical Practice Guidelines Working Group                     To ensure implementing evidence-based practice and decrease variability. The guidelines adapted by local group giving the ownership to the documents.
                                                                                                                                                                                                                                                   
                                                **Educational Support**              Educational activities through CME/CNE/workshops for doctors and nurses                                                                                       To introduce the project tools as guidelines and compare them to the feedback from their practice. Also to cover areas needing increased awareness.
                                                                                                                                                                                                                                                   
                                                **Self-Management**                  Hand held booklet with the patient essential data as agreed on targets for important measures and latest tests result and changes in medications              To empower the patient to be active in the management of his illness.
                                                                                                                                                                                                                                                   
                                                                                     Health Education Facilitator: Health educationist started weekly visits supervising staff involved in the clinics and to emphasis on Self-Management issues   
                                                                                                                                                                                                                                                   
                                                                                     Issuing of free blood glucose monitoring devices for home monitoring                                                                                          
                                                                                                                                                                                                                                                   
                                                                                     Introducing health education forms                                                                                                                            
                                                                                                                                                                                                                                                   
  **IV. Maintenance and Intervention review**   **Audit & Feedback**                 Regular Audits with at least one major audit covering all centers yearly                                                                                      To monitor progress and give feedback to the centers
                                                                                                                                                                                                                                                   
                                                **HCP feedback**                     Continuous communication between implementation team and the HCP in the centers                                                                               To ensure compliance and solve any emerging problems
                                                                                                                                                                                                                                                   
                                                **Patient Feedback**                 During visits and satisfaction questionnaire                                                                                                                  Patient feedback is important measure

Stage I: Included baseline studies on: i) patient flow system in the centers, ii) care of diabetes and hypertension (in 2004) and iii) a community based study carried out in parallel by the same team as ii) with the objective of assessing the prevalence of cardiovascular risk factors in the Al-Ain population. These were generally perceived to be high, but exact data was lacking despite the clear need for this information. Results from this community survey, which was conducted in 2004-2005, also in Al-Ain, have been published elsewhere \[[@B1],[@B16]\].

The flow study (audit) was done in 2003 in all centers. The audit form included information on patient demographics, date/time of attendance, waiting time, reason for and duration of consultation and details of investigations, prescribing, referral and follow-up. After piloting this form all centers were informed about the findings of the audit and given enough time to become familiar with the form. The number of audit days required per center depended on the size of the center and the services provided.

Centers that provided on-call services at weekends were also required to include a weekend. On audit days each patient utilising any service was allocated a form that was completed by all designated staff members including clerk, nurse, and the General Practitioner. Forms were then collated for data entry and analysis. In total 4947 patients were included in the audit. For logistical reasons the flow audit was only repeated after the intervention in the center where the intervention was piloted.

The baseline diabetes and hypertension care audit was conducted in 2004 in all centers. It was repeated annually in all intervention centers during the intervention. Stage II: Basically this stage followed the **P**lan, **D**o, **S**tudy, **A**ct methodology; where the **Plan**of the intervention was developed locally by each center\'s management and implemented by a local team in order to instill a sense of ownership of the project. An overall coordinator (LMB) facilitated the coordination and the running of the project.

In **Do**the intervention evolved from communicating the baseline audit results prior to inaugurating changes in settings or resources. In addition a one day workshop for health professionals, on cardiovascular risk factors was conducted at the end of 2004 highlighting assessment and management of risk by means of the Framingham risk score.

In 2005 an intervention was designed on the basis of the responses from the participating Heath Care Professionals (HCP) to the findings of the audit, including the various educational activities following the audit. The major component of this intervention was the establishment of dedicated clinics for chronic conditions, each being tailored to the local situation where chronic patients had been seen in acute care clinics and had received insufficient attention. Other components of the intervention are shown in Table [1](#T1){ref-type="table"}. The intervention was initially piloted in the academic health center where medical students and family medicine residents receive their training. All tools used in the project, such as forms, registers, policies and guidelines were piloted, tested and improved in this phase.

The additional intervention consisted of facilitating system change, developing decision making aids, educational activities, and a self-management program. The facilitators had well defined roles and were rotating periodically to review the system of implementation depending on the perceived needs or requests of individual health centers. One facilitator (HA&TA) in charge of health education visited the health centers on a fortnightly basis to monitor patient flow and educate the nurses on various aspects of care including the measurement of waist circumference and the calculation of BMI. She also helped the nurses with patient education on such topics as dietetics and foot care. All patients were provided with \"self management cards\" which they were encouraged to take to each consultation. Another facilitator (SZ) monitored the overall system including the booking of patients and appointment attendance rates. The medical record facilitator (SZ&FA) reviewed the charts for the forms and the chronic diseases register, and conducted the patient satisfaction surveys.

Decision making support tools were provided including color coded forms (green for diabetes, pink for hypertension and light green for patients with diabetes and hypertension). These included reminders of care guidelines. The Clinical Practice Guidelines were reviewed and adapted by a local multidisciplinary guidelines group comprising general practitioners, family physicians, nurses and pharmacists, from the centers. Guidelines were modified from ATP III \[[@B17]\] for dyslipidemia, ADA \[[@B18]\] guideline,

ICSI and NICE \[[@B19]\] for Diabetes and NICE \[[@B20]\], JNC 7 \[[@B21]\] and European Hypertension society guideline for hypertension \[[@B22]\]. Also the SNAP \[[@B23]\] guideline was included for therapeutic life style changes. The final draft of these modified guidelines was reviewed by a different group, similarly selected from participating centers. The final guideline was introduced in local Continuing Medical Education (CME) activities by the Guideline Group and HCP were encouraged to consult guideline group members for clarifications.

In addition, workshops for nurses and many CME sessions for doctors were devoted to Diabetes, Hypertension, dyslipidemias, and the assessment and management of cardiovascular risk.

In order to address the problems with time allotment, daily appointment based clinics were instigated in all larger centers to manage patients with diabetes and hypertension.

They were staffed by dedicated nurse and doctor.

In the medium sized centers, with lower patient flow, patients were seen in-between other patients, but with appointments distributed throughout the days of the week for better time management. A telephone visit reminder system was introduced in order to decrease the non-attendance rate.

Over the same period access was improved to both drugs and laboratory investigations.

Centers without their own laboratory were provided with phlebotomist services to obviate the need for referring patients to the central laboratory. Finally, self management was promoted by means of hand held booklets that included all relevant patient data, space for communication with hospital based specialists, as well as self-management measures agreed upon between doctor and patient. Diabetes patients were issued free blood glucose monitoring devices for home monitoring.

Stage III: After the success of the intervention in the pilot center the intervention was expanded to all other city centers. One of the elements learned in the pilot phase and implemented in all centers was how to spread all recommended care over several visits and how to use this to adjust medication. Nurses were involved in ensuring that required investigations were performed prior to the consultation

Stage IV: Maintenance and intervention review. Since the initial intervention an annual audit of diabetes and hypertension care has been conducted in all centers.

Methods of evaluation
---------------------

Changes in standards of care were tracked by chart audits.

The first audit in July 2004 perused 672 files, then after the implementation of the project in the pilot center in 2005 164 files were audited. The audit checklist included information on the process and outcome of care as per guideline recommendations, such as treatments prescribed, documentation of family history, smoking and physical activity, recording of blood pressure, BMI and waist circumference in physical examination and investigations ordered - ECG, Creatinine, HbA1C, lipid profile, and TSH. The auditing was conducted by specially selected nurses temporarily made available by participating health centers.

In 2007 information was extracted from 1402 files. For all patients measures were recorded both before (2006) and after (2007) the intervention. This was repeated in 2008 (715 files). In 2008 three centers were not audited for organizational reasons, and the pilot center was neither audited in 2006 nor in 2008. In order to determine the effect of the intervention the 2008 audit included the same patients audited in 2007, as well as a sample of new patients for comparison. The number of records audited was determined by the size of the center. For large centers a total of around 100, and for medium size centers 60-80 patients was targeted. The attendances for large, medium and small centers are 250-300, 150-200 and 100-150 patients per day respectively.

The chronic disease clinics attracted around 3000 patients per month in the ten centers. Data are not available to determine how many diabetic or hypertensive patients are registered at each center. Although registers are available and each patient has a unique \"disease specific identifier\" (e.g DM91) in these registers, we still found deficiencies and duplications in the registers. In order to avoid problem with sampling from these imperfect registries, a sample was extracted instead from the appointment books of patients attending in the three month period prior to the audit.

Satisfaction of patients about the project was sought through annual interviews. Staff satisfaction was monitored by a constant feedback from the health care professionals to the implementation team. Comments on feasibility and problems associated with the project were elicited during face-to-face interviews by facilitators during regular (more than once weekly) visits to the centres.

Analytical methods
------------------

To compare indicators before and after implementation, standard paired and independent sample t-tests were used where appropriate. SPSS (v 15) was used for all comparisons.

Results
=======

In the patient flow analysis, an obvious mismatch of demands and supply of services was detected (Figure ([1](#F1){ref-type="fig"})). Despite a peak demand between 16:00 to 18:00 daily, staff availability was constant during all 16 opening hours from 8.00 to 23:00. The population characteristics did not show a difference between the study periods with regards to age, sex, duration of disease, or other variables. Diabetes and hypertension on the other hand constitutes almost 13% and 12% of the total number of visits to the centers included in the project in 2004 and 2007 respectively as shown in Table [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

###### 

Characteristics of the patients\' population before and after intervention.

  -------------------------------------------------------------------------------------------------------------------------
                                   2004 (before)\   2007 (after)\                                            
                                   Number (%)       Number (%)                                               
  -------------------------------- ---------------- --------------- -------------- ------------ ------------ --------------
                                   **DM**           **HTN**         **DM & HTN**   **DM**       **HTN**      **DM & HTN**

                                                                                                             

  **Male**                         72 (51.1)        77 (47.8)       207 (55.5)     193 (50.5)   178 (38.9)   184 (43.5)

                                                                                                             

  **Female**                       69 (48.9)        84 (52.2)       166 (44.5)     189 (49.5)   280 (61.1)   239(56.5)

                                                                                                             

  **Age (years)**                                                                                            

                                                                                                             

  \<= 25                           2 (1.4)          2 (1.3)         3 (0.8)        2 (0.5)      7 (1.5)      0 (0)

                                                                                                             

  26-35                            6(4.3)           2 (1.3)         3 (0.8)        9 (2.4)      10 (2.2)     5 (1.2)

                                                                                                             

  36-45                            20 (14.3)        16 (10.1)       41 (11)        64 (16.8)    62 (13.6)    35 (8.3)

                                                                                                             

  46-55                            57 (40.7)        50 (31.6)       114 (30.6)     133 (35)     142 (31.1)   133 (31.4)

                                                                                                             

  56-65                            31 (22.1)        38 (24.1)       126 (33.9)     106 (27.9)   119 (26.0)   135 (31.9)

                                                                                                             

  66-75                            18 (12.9)        39 (24.7)       70 (18.8)      41 (10.8)    74 (16.2)    76 (18.0)

                                                                                                             

  \>75                             6 (4.3)          11 (7)          15 (4)         25 (6.6)     43 (9.4)     39 (9.2)

                                                                                                             

  **Nationality**                                                                                            

                                                                                                             

  UAE                              125 (88.7)       155 (96.3)      351 (94.1)     358 (93.8)   425 (92.8)   392 (92.7)

                                                                                                             

  Non-UAE                          16 (11.3)        6 (3.7)         22 (5.9)       24 (6.2)     33 (7.2)     31 (7.3)

                                                                                                             

  **DM duration**min/max (mode)    1/17 (1)                                        1/32 (3)                  

                                                                                                             

  **HTN duration**min/max (mode)   1/20 (5)                                        1/32 (3)                  
  -------------------------------------------------------------------------------------------------------------------------

\* Patients with (DM) only, \*\* Patients with hypertension only (HTN), \*\*\* Patients with both conditions (DM&HTN).

###### 

Total number of visits of all patients and patients with DM and HTN to the Primary Health Care (PHC) centers participating in the project in 2004 and 2007.

  2007               2004                                                                                                                                                                 
  ------------------ --------- --------------- --------- ---------------- ------------------- ------------------ --------- --------------- --------- ---------------- ------------------- -----------------
  **Total DM&HTN**   **%**     **DM visits**   **%**     **HTN visits**   **No. of visits**   **Total DM&HTN**   **%**     **DM visits**   **%**     **HTN visits**   **No. of visits**   **PHC Centers**
                                                                                                                                                                                          
  7.9                3.7       2140            4.2       2453             57776               14.2               6.1       1975            8.2       2658             32611               **Masoudi**
                                                                                                                                                                                          
  15.2               6.5       2047            8.8       2777             31683               15.1               6         2021            9         3029             33505               **OTC**
                                                                                                                                                                                          
  13.8               6.4       2992            7.4       3431             46449               17.3               7.5       3613            9.8       4687             48054               **Kabisi**
                                                                                                                                                                                          
  13                 5.5       1835            7.5       2510             33509               16.5               7.3       1972            9.2       2507             27148               **Hilli**
                                                                                                                                                                                          
  14.5               6         1511            8.6       2173             25391               14                 5.7       1851            8.4       2733             32683               **Niyadat**
                                                                                                                                                                                          
  11.3               4.8       1150            6.5       1569             23976               11.4               4.6       1285            6.8       1903             28043               **Mueiji**
                                                                                                                                                                                          
  8.8                4.4       3626            4.4       3584             81991               12.3               6.4       3888            5.9       3559             60631               **Mezyad**
                                                                                                                                                                                          
  12                 6         3320            5.9       3252             54915               11.5               5.6       3561            5.9       3740             63675               **Maqam**
                                                                                                                                                                                          
  9.5                4.5       725             5         817              16187               9.3                4.7       1195            4.6       1177             25504               **Zakher**
                                                                                                                                                                                          
  11.7               6.8       2952            4.8       2096             43252               10.1               5.5       3076            4.6       2608             56394               **Yahar**
                                                                                                                                                                                          
  **11.8**           **5.5**                   **6.3**                                        **13.2**           **5.9**                   **7.2**                                        **Average (%)**

HTN Hypertension, DM diabetes mellitus.

![**Flow of patients attending before the intervention in the pilot center and all other 19 (10 urban health centers, 1 labor clinic, 8 rural clinics) centers (over 3 days of the flow audit) and after the intervention in the pilot center (over a whole year)**.](1472-6963-10-47-1){#F1}

In the parallel prevalence study \[[@B1]\] a prevalence of diabetes and hypertension of 23.3% and 21% respectively was found. Despite this high prevalence, the baseline audit of process and outcome of care for these conditions revealed an alarming situation (Table [4](#T4){ref-type="table"}).

###### 

Adherence to recommended care in process measures broken down by the four time periods.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                             2004\                   2006\*\                                             2007\                                                2008\                                     
                             (before intervention)   (after audit feedback and educational activities)   (intervention complete, including structured care)   (follow-up)                               
  -------------------------- ----------------------- --------------------------------------------------- ---------------------------------------------------- ------------- --------- ------- --------- -------
  **Measure assessed**       **No.**                 **%**                                               **No.**                                              **%**         **No.**   **%**   **No.**   **%**

                                                                                                                                                                                                        

  Smoking last visit         541                     80.5                                                1133                                                 89.7          1309      93.4    638       89.2

                                                                                                                                                                                                        

  Physical Activity          7                       1.0                                                 797                                                  63.1          1339      95.5    651       91.0

                                                                                                                                                                                                        

  BMI                        15                      2.2                                                 842                                                  66.7          1334      95.1    624       83.5

                                                                                                                                                                                                        

  Systolic blood pressure    665                     97.2                                                1137                                                 90.0          1395      99.5    657       91.9

                                                                                                                                                                                                        

  Diastolic blood pressure   665                     97.2                                                1137                                                 90.0          1395      99.5    657       91.9

                                                                                                                                                                                                        

  Urine R/E                  174                     25.0                                                590                                                  46.7          850       60.6    591       82.7

                                                                                                                                                                                                        

  Microalbuminurea           0                       0                                                   533                                                  42.2          1105      78.8    598       83.6

                                                                                                                                                                                                        

  Creatinine                 88                      13.0                                                846                                                  67.0          1263      90.1    NA        NA

                                                                                                                                                                                                        

  HbA1c (in DM)              115                     22.9                                                411                                                  51.1          785       89.4    349       76.0

                                                                                                                                                                                                        

  Total cholesterol          323                     47.7                                                836                                                  66.7          1268      90.4    574       80.3

                                                                                                                                                                                                        

  LDL                        74                      10.9                                                555                                                  56.1          1247      88.9    569       79.6

                                                                                                                                                                                                        

  HDL                        49                      7.2                                                 693                                                  54.9          1264      90.2    572       80.0

                                                                                                                                                                                                        

  TG                         321                     47.4                                                834                                                  66.0          1256      89.6    574       80.3

                                                                                                                                                                                                        

  Ophthalmology referral     37                      5.5                                                 278                                                  22.0          712       50.8    224       31.3
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Pilot center excluded, NA not assessed

Outcome: With the structured care intervention piloted in 2005-2006 measures of quality of care were constantly improving. This started with a correction in the management of patient flows. This was improved by moving patients with identified specialized needs of care such as antenatal care, well baby care, and chronic diseases to special, appointments based, clinics (Figure [1](#F1){ref-type="fig"}). Thus, after this change, in the pilot center, 24% of consultations were for appointment in the specialized clinics, which 77.4% of the patients attended for more than 6 months and 65.2% for a whole year. This flow management obviated the need for hiring additional staff, in fact hiring was frozen for the period of the project and several staff had even left as a result of retirement or moving jobs.

In the ongoing post-intervention audits indicators of process and outcome of care showed significant improvements (Tables, [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"} and [7](#T7){ref-type="table"}), including documentation of patients\' history, examinations and investigations (Table [4](#T4){ref-type="table"}). This notably included recording of smoking status and blood pressure, irrespective of reason for attendance.

###### 

The change outcome measures over the 4 time-periods.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                  2004\                   2006\*\                                             2007\                                                2008\
                                  (before intervention)   (after audit feedback and educational activities)   (intervention complete, including structured care)   (follow-up)
  ------------------------------- ----------------------- --------------------------------------------------- ---------------------------------------------------- -------------
                                  **%**                   **%**                                               **%**                                                **%**

                                                                                                                                                                   

  Smoking last visit (males)      16.4                    13.4                                                12.7                                                 13.2

                                                                                                                                                                   

  Physical Activity               70.0                    56.8                                                62.7                                                 42.7

                                                                                                                                                                   

  BMI (% \<30)                    31.2                    56.5                                                54.8                                                 58.1

                                                                                                                                                                   

  Blood Pressure control in HTN                                                                                                                                    

                                                                                                                                                                   

  \% Blood pressure \<= 140/90    57.0                    51.1                                                72.9                                                 67.5

                                                                                                                                                                   

  Blood Pressure control in DM                                                                                                                                     

                                                                                                                                                                   

  \% Blood pressure \<= 130/80    31.0                    32.4                                                51.6                                                 42.9

                                                                                                                                                                   

  HbA1c (% \< 7) in DM            18.3                    41.4                                                43.1                                                 45.6

                                                                                                                                                                   

  HbA1c (% \< 9) in DM            47.0                    69.5                                                77.7                                                 80.0

                                                                                                                                                                   

  HbA1c (% \< 10) in DM           61.7                    79.6                                                88.3                                                 90.0

                                                                                                                                                                   

  Total cholesterol (\<200)       25.0                    50.8                                                73.1                                                 79.6

                                                                                                                                                                   

  LDL (\<100 in DM)               21.1                    26.9                                                34.9                                                 39.4

                                                                                                                                                                   

  LDL (\<130 in HTN)              10.0                    40.4                                                60.6                                                 59.0

                                                                                                                                                                   

  HDL (\>40)                      48.9                    56.3                                                54.4                                                 20.0

                                                                                                                                                                   

  TG (\<150)                      25.8                    67.1                                                77.3                                                 81.3
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Paired t-test of outcome measures comparing before and after the intervention.

                                    (2006 mean-2007mean)\*   No.   P value       (2007 Mean-2008 Mean)\*\*   No.   P value
  --------------------------------- ------------------------ ----- ------------- --------------------------- ----- -------------
  **Hypertension**                                                                                                 
                                                                                                                   
  **BMI**                           29.8-29.9                675   **0.81**      29.2-29.6                   421   **0.4**
                                                                                                                   
  **HbA1c in DM**                   8.0-7.3                  265   **\<0.001**   7.19-7.17                   218   **0.8**
                                                                                                                   
  **Total cholesterol**             200.7-184.6              634   **\<0.001**   185.8-162.3                 408   **\<0.001**
                                                                                                                   
  **LDL**                           130.9-118.8              538   **\<0.001**   119.0-104.9                 403   **\<0.001**
                                                                                                                   
  **HDL**                           43.5-43.46               537   **0.9**       44.0-40.2                   410   **0.07**
                                                                                                                   
  **TG**                            138.9-122.2              624   **\<0.001**   125-105.6                   406   **\<0.001**
                                                                                                                   
  **Diabetes Mellitus**                                                                                            
                                                                                                                   
  **BMI**                           29.2-29.4                572   **0.015**     28.5-29.2                   383   **0.015**
                                                                                                                   
  **HbA1c in DM**                   8.4-7.7                  436   **\<0.001**   7.8-7.6                     321   **0.035**
                                                                                                                   
  **Total cholesterol**             197.8-180.9              557   **\<0.001**   184.1-155.0                 370   **\<0.001**
                                                                                                                   
  **LDL**                           126.5-113.5              478   **\<0.001**   115-98.1                    366   **\<0.001**
                                                                                                                   
  **HDL**                           42.9-43.0                478   **0.8**       44.1-40.4                   370   **0.019**
                                                                                                                   
  **TG**                            148.2-130                552   **\<0.001**   131.86-107.6                369   **\<0.001**
                                                                                                                   
  **Blood pressure control**                                                                                       
                                                                                                                   
  **In patients with DM**                                                                                          
                                                                                                                   
  **Systolic BP**                   125.4-122.2              179   **\<0.001**   122.2-122.3                 189   **0.13**
                                                                                                                   
  **Diastolic BP**                  79.8-76.6                179   **\<0.001**   76.7-75.3                   189   **0.01**
                                                                                                                   
  **In patients with HTN**                                                                                         
                                                                                                                   
  **Systolic BP**                   138.9-132.8              414   **\<0.001**   133.2-131.6                 226   **0.07**
                                                                                                                   
  **Diastolic BP**                  85.8-81.3                415   **\<0.001**   82.3-79.4                   228   **\<0.001**
                                                                                                                   
  **In patients with HTN and DM**                                                                                  
                                                                                                                   
  **Systolic BP**                   137.8 -131.9             389   **\<0.001**   133.1-134.7                 237   **0.1**
                                                                                                                   
  **Diastolic BP**                  83.5-79.9                389   **\<0.001**   83.4-80.2                   237   **0.002**

\*2006-2007 indicates the change in 2007 compared to 2006

\*\* 2007-2008 indicate the change in 2008 compared to 2007

###### 

The change in prescribing diabetic medications in diabetics and blood pressure lowering medications in hypertensives in the 4 time-periods.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                      2004\                   2006\                                               2007\                                                2008\                                        
                      (before intervention)   (after audit feedback and educational activities)   (Intervention complete, including structured care)   (follow-up)                                  
  ------------------- ----------------------- --------------------------------------------------- ---------------------------------------------------- ------------- --------- ---------- --------- ----------
                      **No.**                 **%**                                               **No.**                                              **%**         **No.**   **%**      **No.**   **%**

                                                                                                                                                                                                    

  **Aspirin**         212                     **31.3**                                            412                                                  **32.6**      834       **59.5**   481       **67.3**

                                                                                                                                                                                                    

  **Statin**          204                     **30.1**                                            388                                                  **30.7**      621       **44.3**   427       **59.7**

                                                                                                                                                                                                    

  **Other LLM**       NA                      NA                                                  NA                                                   NA            146       **10.4**   82        **11.5**

                                                                                                                                                                                                    

  **DM Rx**                                                                                                                                                                                         

                                                                                                                                                                                                    

  **No medication**   67                      **13.3**                                            82                                                   **20.6**      25        **6.1**    25        **6.1**

                                                                                                                                                                                                    

  **1 medication**    255                     **50.5**                                            133                                                  **33.4**      104       **25.4**   78        **19.0**

                                                                                                                                                                                                    

  **2 medication**    174                     **34.5**                                            140                                                  **35.2**      194       **47.4**   198       **48.3**

                                                                                                                                                                                                    

  **3 medication**    8                       **1.5**                                             42                                                   **10.6**      77        **18.8**   90        **22**

                                                                                                                                                                                                    

  **4 medication**    0                       **0**                                               1                                                    **0.3**       9         **2.2**    19        **4.6**

                                                                                                                                                                                                    

  **On Insulin**      NA                      **NA**                                              NA                                                   **NA**        47        **5.8**    18        **4.5**

                                                                                                                                                                                                    

  **HTN Rx**                                                                                                                                                                                        

                                                                                                                                                                                                    

  **No medication**   57                      **10.7**                                            101                                                  **20.2**      33        **7.3**    20        **2.2**

                                                                                                                                                                                                    

  **1 medication**    28                      **52.8**                                            196                                                  **39.3**      174       **38.4**   163       **16.5**

                                                                                                                                                                                                    

  **2 medication**    156                     **29.3**                                            116                                                  **23.2**      185       **40.8**   187       **41.1**

                                                                                                                                                                                                    

  **3 medication**    32                      **6.0**                                             28                                                   **5.6**       57        **12.6**   75        **35.8**

                                                                                                                                                                                                    

  **4 medication**    6                       **1.1**                                             3                                                    **0.6**       4         **0.9**    10        **4.4**
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA, not assessed

Also, the recording of BMI improved substantially from 2.2% in 2004 to 95.1% in 2007. Most likely only apparently obese patients had their BMI recorded in 2004 as around 70% of them had BMIs above 30 kg/m2.

Adherence to Clinical Practice Guidelines adopted by the project, (Table [4](#T4){ref-type="table"}) regarding recommended investigations such as kidney function tests, HbA1c and lipid profiles, clearly improved. In 2004 these were available for very few patients but this improved in 2006-2007 following the structured care intervention, and permission given (in 2005) to General Practitioners to order LDL and HDL tests.

With regards to outcome, neither smoking cessation nor BMI were much affected by the intervention. Smoking dropped from 16.4% in 2004 to around 13% in subsequent years while obesity was consistently prevalent in approximately 50% of patients (Table [5](#T5){ref-type="table"}, Table [6](#T6){ref-type="table"}).

In contrast, measures of disease control in diabetes and hypertension improved. Blood pressure control was impressive and significantly improved with around two third of patients meeting target values of 140/90 or less in, 2007 and 2008 (Table [5](#T5){ref-type="table"}, Table [6](#T6){ref-type="table"}).

HbA1c in diabetics had dropped significantly with 80% having values below 9 in 2008 compared to 61.7% in 2004 and 69.5% in 2006. The median dropped from 8 in 2006 to 7.5 in 2007 and to 7.2 in 2008 which was significant by paired t-test, (Table [5](#T5){ref-type="table"}, Table [6](#T6){ref-type="table"}). Systolic blood pressures in diabetics dropped significantly in 2007, from an average of 125.4 in 2006 to 122.2 in 2007 and remained the same in 2008. Diastolic blood pressure on the other hand, kept improving over years, (Table [6](#T6){ref-type="table"}). Nevertheless, around half the diabetics met the recommended target of 130/80 in 2007 compared to one third in 2006 and 2004, (Table [5](#T5){ref-type="table"}).

Lipid profiles showed a significant improvement in total cholesterol, LDL and triglycerides, since more than three quarter of patients met target values in 2007 and 2008 compared to only a third in 2004 and a half in 2006 (Table [5](#T5){ref-type="table"}). However, this was not the case for HDL which remained the same or even significantly dropped in the case of diabetics in 2008. Figure [2](#F2){ref-type="fig"} shows the changes in all these indicators. These changes in disease control measures reflected significant increases in prescriptions of aspirin and statins by General practitioners as shown in Table [7](#T7){ref-type="table"}. Prescribing of aspirin and lipid modifying agents increased from one third of patients in 2004 and 2006 to two thirds in the structured care intervention years in case of aspirin and to half of the patients in case of statins.

![**The change in the main outcome measures during the years of the project**. **a**. HbA1c, **b**. Total Cholesterol, **c**. Triglycerides, **d**. Systolic Blood Pressure (SBP), **e**. Diastolic Blood Pressure (DBP).](1472-6963-10-47-2){#F2}

The number of medications per patients also increased over the intervention years. For example, more than three quarters of diabetes or hypertension patients were on two or more medications in 2008, reflecting current guidelines. Insulin use in diabetics, however, was less than 5% in both 2007 and 2008.

Ophthalmology referrals markedly increased from 5.5% in 2004 to 50.8% in 2007 but decreased to 31.3% in 2008. However, other recommended referrals such as dental, nutritional and vaccination for influenza and pneumonia were not audited, since routine referral to these services was impossible due to limited resources and large case loads.

In addition, the number of patients diagnosed with diabetes or hypertension increased in recent years as evident from Figure [3-a](#F3){ref-type="fig"} and [3-b](#F3){ref-type="fig"}.

![**3-a. The duration of diabetes in the studies population in relation to age, 3-b**. The duration of hypertension in the studied population in relation to age.](1472-6963-10-47-3){#F3}

Discussion
==========

Starting with the care audits showing very poor levels of care in 2004 similar to an earlier audit carried out in 1998 \[[@B24]\] and the interventions implemented, the initial audit with feedback coupled with educational activities clearly led to a marked improvement as indicated by a notable change in indicators between 2004 to 2006. These elements were particularly effective in other studies where the baseline adherence to recommended practices was low and the intensity of audits and feedback was high \[[@B25]\].

Nevertheless, most improvements occurred only later with the second structured intervention introduced after 2006 that directly targeted the delivery of services to patients with chronic conditions by introducing special dedicated clinics. The success of structured intervention makes it clear that the lack of knowledge of health care professionals\' may be less of a constraint than other structural factors. Improvements seen in our project were comparable to local and international benchmarking figures for good clinical care for both diabetes and hypertension \[[@B26]-[@B31]\].

Improvements were achieved in both process and the outcome of care (Table [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}) in response to different elements of the project. Specifically, the change in drug prescriptions (Table [7](#T7){ref-type="table"}) came after structured care was introduced, suggesting that the additional resources (time!) available per patient to adjust patients\' management plans paid off. Prescribing aspirin and statins had increased steadily, but unfortunately we were unable to assess whether the increase were in accordance with good practice guidelines. Nevertheless, our figures are comparable to other research-based interventions that at best reached 75 and 88% \[[@B6]\]. In contrast, insulin is still prescribed infrequently, \<5% in both 2007 and 2008. Whether this is due to doctors\' inexperience in using insulin or patients\' preferences remains unclear and is an area for future study.

Systolic blood pressure in diabetics remained constant in 2008 after having improved in 2007. In contrast, diastolic blood pressure, HbA1c and most lipid profiles improved with time. Perhaps, doctors were not targeting blood pressure enough in diabetic patients to meet the recommended standards, and may have been more focused on controlling blood sugar and HbA1C. Patients also might have paid insufficient attention to their blood pressure if they are not hypertensive. Nevertheless, as a blood pressure control (particularly systolic blood pressure) is neither \'frequently nor easily obtained\' \[[@B32]\], this area may need additional measures especially because lowering blood pressure in diabetics is cost saving \[[@B5]\].

Ophthalmology referrals improved from 5.5% in 2004 to 50.8% in 2007, but decreased to 31.3% in 2008. This decrease may be due to doctors\' loss of adherence to recommended care or due to patients\' reluctance to accept long hospital waiting times. Better coordination of care with local hospitals in important areas, such as ophthalmology and nephrology, clearly needs improvement.

Unfortunately, our interventions were less successful in redressing life-style related risk factors, such as obesity, physical inactivity and smoking. These domains may need more time and resources, with perhaps a different type of intervention \[[@B33]\]. A deficiency in our project was a lack of nutritionists and health education specialists in the participating centers to reinforce efforts by other HCPs and assess patients\' self-management. A recent study suggested that absence of such resources was a major barrier to weight management in Emirati women at risk of DM, as perceived by HCP \[[@B33]\]. Self-management may be another important tool in addressing life-style factors. In our intervention, a hand-held booklet specifying goals in the self management of their illness was distributed to all patients. Also many patients were advised to obtain a home blood pressure monitoring device and a glucometer with strips, which has been freely available since 2007 for diabetic patients. However, the success (or lack of it) of these measures remain to be fully analyzed and understood. For self-management to succeed, both health service support and the acceptance by the patients of their responsibility are crucial. Historically in our culture (and elsewhere), patients often delegated their responsibility in this respect to the doctors they trusted, as this is a meaningful attitude for many other conditions.

The increase in diagnoses of diabetes and hypertension in recent years could be due to various factors, such as a change in cut-off values, intensified screening, as well as a true increase in prevalence. Strategies used in this project, with an organized system of regular follow-up and the use of dedicated clinics \[[@B34]\] significantly improved the care of chronic disease patients \[[@B9]-[@B15]\] and may also have improved the case detection rate. Nevertheless, the number of patients treated for diabetes and hypertension in our clinics falls short of the estimated total number of affected individuals, and many patients currently remain untreated, which clearly needs to be addressed in futures interventions.

Collaboration with health care staff working in the centers is key to success. While some aspects of the intervention may be experienced as stressful, we found that many were particularly content with the dedicated clinics, but a full analysis of their experiences remains to be done. Other important elements of this project were chart reminders and educational meetings which were shown to be effective, but only in combination with other strategies \[[@B35],[@B36]\] since educational meetings alone were likely to be effective in changing complex behaviors \[[@B37]\].

Our findings also have relevance for other Gulf countries as many resemble the UAE in their high cardiovascular risk profile as well as their health care system. In addition, our approach may be extended to the management of other chronic conditions. Yet each intervention may need to be piloted separately, as a major limitation of our study was its confinement to a single city in one country, and with a single project management throughout, makings it difficult to generalize to other places and circumstances.

Nevertheless, a major lesson to be learnt from this experience is the value of a single centrally coordinated primary health care system in this city, which facilitated the project and made it a relatively cost effective intervention. This is more obvious if we compare this project to a similar project implemented in the United States targeting the care of chronic diseases on the basis of payment for performance \[[@B38]\]. Financial incentives were necessary in a fragmented primary health care system consisting of isolated different sized practices to implement similar interventions through programs such as Physician Quality R Initiative (PQRI) \[[@B39]\].

Sustainability of the improvements is a major concern. Inevitably, changes in the organization that affect the program occur. Early in 2008 three centers were moved to another managing body and in July 2008 the other centers of the department of Primary Health Care were brought under new administration. \"Old\" projects such as our intervention were allocated a low priority. Also we lost one of the facilitators. In spite of these two factors, decreased administrative endorsement and loss of the facilitator, the program was successfully maintained by the centers\' staff. Yet, Tables [4](#T4){ref-type="table"} &[5](#T5){ref-type="table"} demonstrate an overall lack of further improvements and a trend to a decline in some key measures but as in Table [6](#T6){ref-type="table"} none of the decline was significant. And in a more recent audit in 2009, the quality of care was very similar to that found in 2008, which is reassuring for the second year after the change.

We believe that because the project was initiated internally with no external intervention (not ready for the implementation plan and no new people allowed the change) gave a sense of ownership among centers, probably facilitating sustainability.

However, for further improvements, e.g. for diabetics with hypertension, managing nephropathy, self-management of life-style factors, shared care with the hospital, optimizing dyslipidemia management etc., and additional components still to be developed, should be added to the project.

The limitation of this study is mainly its descriptive nature and that it compares after to before the intervention rather than being a factorial randomised controlled study. This makes it difficult to attribute the success of the project to specific components and reduces its external validity.

Conclusion
==========

We believe that awareness of the problem of diabetes and hypertension in our community, and the clear need to have special organized care for this group of patients in the health care system, may have facilitated the uptake and sustainability of the project. But awareness is not sufficient, since without the other project components - specifically the dedicated personnel and clinics - the intervention would not have been maintained.

Competing interests
===================

The authors declare that they have no competing interests.

Authors\' contributions
=======================

LMB: Coordinated the project and wrote MS, AIS: Member in project working group,

TAA: Member in project working group, LAM: Member in project working group, MHK: Member in project working group, TAA: Project Facilitator and Member in project working group, NJDN: Statistical advice and contributed to MS writing, AMA: Member in project working group, NMA: Member in project working group, SMZ: Project Facilitator and Member in project working group, TMJ: Member in project working group, AME: Member in project working group, ADR: Member in project working group, AIA: Member in project working group, FAN: Member in project working group, HOA: Project Facilitator and Member in project working group, MKN: Member in project working group, RA: Member in project working group, YOZ: Member in project working group, AOO: Project Facilitator and Member in project working group. All Authors have read and approved the final manuscript.

Pre-publication history
=======================

The pre-publication history for this paper can be accessed here:

<http://www.biomedcentral.com/1472-6963/10/47/prepub>
